Below is a list of companies and organisations that have already registered to attend this years Forum.

Abbott Bioresearch Center
Abcam
Ablynx
Accelsiors Group International
Access International, LLC
Ace BioSciences
Acorda Therapeutics Inc.
Acretia Inc.
Adams, Harkness & Hill, Inc.
Aderis Pharmaceuticals
Adherex Technologies Inc.
Advent International
Advent International
Aegera Therapeutics
AG Edwards & Sons
Air Force Research Laboratory
Alantos Pharmaceuticals
Ambit Biosciences
AMEX
Amphora Discovery Corporation
Anglo Irish Bank
ANZACC of New England
Arrow Therapeutics
Ascension Health Ventures
AstraZeneca
Atlas Venture
Atugen AG
Aureon Biosciences Corporation
Aurora Discovery, Inc.
Avidex
Avitar
BD (Becton Dickinson and Company)
Bellevue Asset Management
Beth Israel Deaconess Medical Center
Biogen Idec
BIO-IT WORLD
BioLineRx
BioMassive
Biophan Technologies Inc
BioSante Pharmaceuticals Inc
BioStrategy Consulting Group
Bioteam Paris Region
BioValley-Basel Area Business Development
BioVentures Investors
Biovex
BioVeda Capital
Bioworld Today
Boehringer Ingelheim GmbH
Boston Millennia Partners
Brigham and Women's Hospital
British Consulate-General
Bund Capital Ltd
Burrill & Co
Cambria Biosciences LLC
Cambridge Associates LLC
Canadian Consul (Investments)
Canadian Consulate General in Boston
Capital Funding
CapMan
Cardinal Partners
Catalyst Health and Technology Partners
CB Health Ventures
CBT Advisors
CDIB BioScience Venture Management
Cell Signaling Technology
Connecticut Innovations
CPP Advisors LLC
Cryptome Pharmaceuticals
Cubist Pharmaceutical
Curis
Deloitte & Touch LLP
DeveloGen AG
Edelson Technology Partners
EGS Healthcare
Eli Lilly & Company
Enobia Pharma
EPIX Pharmaceuticals
Excel PharmaStudies
Favrille Inc
Feinstein Kean Healthcare
Ferghana Partners
Ferraris Group plc
Fidelity Biosciences Group
Flagship Ventures
Foley Hoag LLP
French Embassy Trade Office
Friedman, Billings, Ramsey
Genencor International
Genzyme Corporation
Global Markets Capital Group, LLC
Grant Life Sciences
Greater Zurich Area
GSAS Harvard Biotechnology Club
Hambrecht & Quist Capital Management
Harvard - MIT Biomedical Enterprise Program
Harvard Biotechnology Club
Harvard Clinical Research Institute
Harvard Medical School
Harvard University
Harvard University Engineering and Applied Sciences
HCRI
Health Advances, LLC
Health Products Development, Inc.
Henry M. Jackson Foundation
Hub Management Investment Group
IBM
Iconix Pharmaceuticals Inc
IMS Health
ING Bank Belgium
Intercell AG
Invest Australia
Johns Hopkins University, Office of Licensing & Technology Development
Katan Associates
Ken Clark International
KBL Healthcare Ventures
Knights Equity Markets
LaVoie Strategic Communications Group, Inc.
Leerink Swann & Company
Librophyt
Life Medical Sciences Inc
Life Point
Lipocine Inc.
Lombard Odier Darier Hentsch & Cie
Louisiana Fund I
M. I. T.
MacroChem Corporation
MARCO POLO PARTNERS LLC
Mancino Burfield Edgerton
Massachusetts General Hospital
Mass High Tech
MDJ Consulting
MDS Capital
MedExGen
Medicago Inc
Medtronic
Memorial Sloan Kettering Cancer Cente
Merck & Co
Merrimack Pharmaceuticals
MethylGene Inc.
Millennium Pharmaceuticals, Inc.
MIT Sloan School of Management
Molecular Immunology Foundation
Montridge LLC
Moors & Cabot, Inc.
MPM Capital
Neurobiological Technologies
Neuromed Technologies Inc.
Nexus Medical Partners
NGN Capital
NIF Ventures
Norwood Abbey Limited
NOVACE Corporation
NovaDel Pharma Inc.
Novartis
Novation, Inc.
Novotech
OncoMethylome Sciences
Oppenheimer & Company
Orexo AB
Oxford Bioscience Partners
Oxford Finance Corporation
Palatin Technologies Inc
Palmer & Dodge
Paloma Pharmaceuticals, Inc.
Partners Healthcare
PBL Therapeutics
Percadia
Perlegen Sciences Inc
PhageTech Inc
Pharmamar
Pharmaprojects
PIERIS Proteolab AG
Polaris Venture Partners
Polymedix
PolyTechnos Venture-Partners
Praecis Pharmaceuticals, Inc.
Psychiatric Genomics Inc.
PureTech Development LLC.
PureTech Ventures
RA Capital Management
Radcliffe Consulting, Inc
Rock Hill Ventures
Rockport Venture Partners
RX Communications
Safeguard Scientifics, Inc.
Santhera Pharmaceuticals AG
Schroder Venture Life Sciences
Scientific Legacies
Scil Technology GmbH
Seaflower Ventures
Selecore GmbH
Semaphore
Serenex Inc
Serono
SG Cowen Securities Corporation
SHARE, Consulate of Switzerland
Sherbrook Capital Management, LLC
Siemens Venture Capital
Silicon Valley Bank
Sirtris Pharmaceuticals
Speedel Pharmaceuticals Inc
Spray Venture Partners
Still River Funds
SV Life Sciences
Swifton Equity Advisors
Swiss Biotech Association
SWX Swiss Exchange
Sycamore Ventures
Synta Pharmaceuticals
Technology Review
The Abajian Group
The CBR Institute for Biomedical Research
The Dow Chemical Company
The Ruth Group
Thermo Electron
Tiger Advisors LLC
Topigen Pharmaceuticals Inc
TransMolecular
Transpharma-Medical
Transvera Technologies / Harvard University
Trillium Medical Ventures
Tufts University
TVM
UBS
University of South Florida, College of Medicine
VantagePoint Venture Partners
Vela Pharmaceuticals Inc
Venture Valuation
Viventia Biotech Inc
Wachovia Securities
Warburg Pincus
Whitehead Institute for Biomedical Research
WulffCapital, LP
Wyeth Pharmaceuticals
Xanthus Life Sciences, Inc.
YM Biosciences
Zelos Therapeutics
Zeltia S.A.
Zero Stage Capital